Pharmaceutical stocks opened strongly on May 14 2026 during the early morning trading session. The sector witnessed broad-based buying interest with most stocks trading in the green. The BSE Healthcare index rose 1.27% to 46,735.35, clearly outperforming the broader market. The Nifty 50 was up 0.67% at 23,569.45 and the S&P BSE Sensex gained 0.55% to 75,019.03 as of around 9:26 AM.
Top Gainers in Pharma Sector
- Cipla emerged as the biggest gainer, surging 7.15% on BSE to ₹1,422 and 6.11% on NSE to ₹1,408.70.
- Zydus Lifesciences advanced 3.74% on BSE to ₹974.05 and 4.01% on NSE to ₹976.90.
- Strides Pharma Science gained 2.20% on BSE to ₹1,171.45.
- Wockhardt rose 2.12% on BSE to ₹1,601.95.
- Orchid Pharma was up 2.13–2.34%.
Other notable gainers included IPCA Labs, Glenmark Pharma, Aurobindo Pharma, Lupin, Mankind Pharma, Ajanta Pharma, Alembic Pharma, Torrent Pharma , Natco Pharma , and Aarti Drugs.
Stocks such as Biocon, Divis Laboratories, J.B. Chemicals, Sun Pharma, and Sudeep Pharma Ltd. also traded with modest gains ranging from 0.5% to 1.7%.
Minor Losers
- Dr. Reddy’s Lab and Panacea Biotech were among the few stocks trading marginally lower in the early session.
Overall, the pharma sector started the day on a positive note with widespread gains across large-cap, mid-cap, and small-cap stocks.
Note: All prices and percentage changes are based on data as of 9:21 AM on BSE and 9:24 AM on NSE on May 14 2026. Market prices are volatile and continue to change rapidly. This is for informational purposes only and does not constitute investment advice. For the latest live prices, please check the official NSE and BSE websites.